Works matching IS 11707690 AND DT 2000 AND VI 17 AND IP 2
Results: 9
Diagnosis related group costs in a regulated environment. A note about their economic interpretation.
- Published in:
- 2000
- By:
- Publication type:
- journal article
New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Pharmacoeconomic considerations in treating ovarian cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Valuing Health-Related Quality of Life: A Review of Health State Valuation Techniques.
- Published in:
- PharmacoEconomics, 2000, v. 17, n. 2, p. 151, doi. 10.2165/00019053-200017020-00004
- By:
- Publication type:
- Article
The costs of pharmacological treatment for major depression. The Italian Prospective Multicentre Observational Incidence-Based Study.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza. Zanamivir Study Group.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).
- Published in:
- 2000
- By:
- Publication type:
- journal article
Economic analysis of long-term reversible contraceptives. Focus on Implanon.
- Published in:
- 2000
- By:
- Publication type:
- journal article